Warak Chaovapong
About
In The Last Decade
Warak Chaovapong
10 papers receiving 372 citations
Peers
Comparison fields: 5 of 59
- Radiology, Nuclear Medicine and Imaging 310
- Oncology 122
- Molecular Biology 112
- Organic Chemistry 41
- Hematology 36
Countries citing papers authored by Warak Chaovapong
This map shows the geographic impact of Warak Chaovapong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warak Chaovapong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warak Chaovapong more than expected).
Fields of papers citing papers by Warak Chaovapong
This network shows the impact of papers produced by Warak Chaovapong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warak Chaovapong. The network helps show where Warak Chaovapong may publish in the future.
Co-authorship network of co-authors of Warak Chaovapong
This figure shows the co-authorship network connecting the top 25 collaborators of Warak Chaovapong. A scholar is included among the top collaborators of Warak Chaovapong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warak Chaovapong. Warak Chaovapong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 71 | |
| 2 | 3 | |
| 3 | Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent. | 15 |
| 4 | Pharmacokinetics of pretargeted monoclonal antibody 2D12.5 and 88Y-Janus-2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecanetetraacetic acid (DOTA) in BALB/c mice with KHJJ mouse adenocarcinoma: a model for 90Y radioimmunotherapy. | 72 |
| 5 | Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake. | 41 |
| 6 | Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens. | 159 |
| 7 | 3 | |
| 8 | 4 | |
| 9 | Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. | 30 |
| 10 | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.